We show that the EGFR-signaling pathway complements this list albeit that it acts a bit different in that it suppresses the type 1 cytokine mediated amplification of tumor infiltration by T cells, via blockade of the production of T-cell attracting chemokine by tumor cells when stimulated with type 1 cytokines. The gene discussed is EGFR; the disease is neoplasm.